Document Detail


Yellow Brain Culinary-Medicinal Mushroom, Tremella mesenterica Ritz.:Fr. (Higher Basidiomycetes), is Subjectively but not Objectively Effective for Eradication of Helicobacter pylori: A Prospective Controlled Trial.
MedLine Citation:
PMID:  22339708     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
Inhibitory effects of the higher Basidiomycetes mushrooms, including species of genus Tremella, on the growth of Helicobacter pyroli (Hp) have been described. This study aimed to test T. mesenterica (Tm) efficacy in vivo on eradication of Hp. This IRB-approved study included 52 consenting patients diagnosed with Hp infections. The patients were selected for 10-day treatments with one of the three arms of the protocol, namely, (i) Tm 2 g, (ii) Tm given with omeprazole 20 mg, or (iii) omeprazole 20 mg, clarithromycin 500 mg, and amoxicillin 1000 mg (all regimens given twice daily). The Tm submerged cultivated mycelium in the form of tablets (1 g) was supplied free of charge to patients. Three weeks after completing the therapy, breath testing was assessed for Hp eradication. The patients who took the standard triple therapy had a 70% (n = 14) eradication rate of Hp. Of the patients taking Tm, with and without omeprazole, only one had a breath test indicative of eradication of Hp, p < 0.000. Tm-treated patients had fewer adverse events and equivalent symptomatic relief. Limitations of this study include the brief duration of Tm therapy. Longer treatment might achieve better results, but was judged to be not warranted, so as to not excessively further delay accepted therapy. Ten-day Tm was not found to be effective in vivo in eradicating Hp, whether if given with or without omeprazole. Significant symptomatic relief found among Tm-treated patients suggests that further study of Tm is well justified.
Authors:
Jesse Lachter; Yevgeny Yampolsky; Ronit Gafni-Schieber; Solomon P Wasser
Related Documents :
16440068 - Declining emergency department visits and costs during the severe acute respiratory syn...
1745618 - Fixed-rate reimbursement fails to cover costs for patients with delayed graft function.
12355478 - Modeling the progression of rheumatoid arthritis: a two-country model to estimate costs...
17309908 - Comparison of clinical and economic outcomes of two antibiotic prophylaxis regimens for...
21661448 - Low peritoneal and systemic inflammatory response after laparoscopy-assisted gastrectom...
182698 - Treatment of fractures of the femoral neck by replacement with the thompson prosthesis.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  International journal of medicinal mushrooms     Volume:  14     ISSN:  1521-9437     ISO Abbreviation:  Int J Med Mushrooms     Publication Date:  2012  
Date Detail:
Created Date:  2012-02-20     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  100886202     Medline TA:  Int J Med Mushrooms     Country:  United States    
Other Details:
Languages:  eng     Pagination:  55-63     Citation Subset:  IM    
Affiliation:
Faculty of Medicine and Gastroenterology: Rambam Health-Care Campus, Technion - Israel Institute of Technology.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Antibacterial Activity of Wild Xylaria sp. Strain R005 (Ascomycetes) Against Multidrug-Resistant Sta...
Next Document:  Pleurotus opuntiae (Durieu et Lev.) Sacc. (Higher Basidiomycetes) and Other Species Related to Agave...